Medical Strategy - Biotech Investors Revenue
Investment Management • 
Bahnhofstr. 7, Gräfelfing, Germany • 11-20 Employees
Medical Strategy - Biotech Investors revenue & valuation
| Annual revenue | $1,112,215 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Investment Management industry and current estimated revenues | $3,600,000 |
| Total funding | No funding |
Key Contact at Medical Strategy - Biotech Investors
Thomas Vorlicky
Geschäftsführer / Managing Director
Company overview
| Headquarters | Bahnhofstr. 7, Gräfelfing, Bayern 82166, DE |
| Website | |
| NAICS | 5231 |
| SIC | 873 |
| Keywords | Healthcare Investmentberatung-/Management |
| Founded | 1992 |
| Employees | 11-20 |
| Socials |
Medical Strategy - Biotech Investors Email Formats
Medical Strategy - Biotech Investors uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@medicalstrategy.de), used 54.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@medicalstrategy.de | 63.6% |
{f2}{last name} | {f2}doe@medicalstrategy.de | 18.2% |
{first name}{last name} | johndoe@medicalstrategy.de | 18.2% |
About Medical Strategy - Biotech Investors
Within the scope of our core competence, we focuse exclusively on the management and advisory of equity portfolios in the healthcare/biotech sector. **Objective** Our primary goal is to identify innovations in the healthcare sector at an early stage - in order to generate above-average long-term results for investors by investing in low-rated growth companies. In our inhouse database, we systematically document and analyze over 900 companies from the international healthcare sector. This information base is constantly being expanded through in-house and external specialized research. **Flexibility** All segments of the healthcare sector are open to us for our investment decisions. In doing so, we do not orientate ourselves to the standardized benchmarks. Rather, we make targeted investments in companies that are not threatened by a drop in sales, but which show a high dynamic for value enhancement through innovative strength. **Experience and deep understanding** The team of Medical Strategy is made up of experts with complementary backgrounds and decades experience in both the health and financial sectors together. This results in a profound understanding of the scientific and investment relevant developments in the healthcare market. We continuously analyze listed companies in all relevant segments of the healthcare sector. **Independence - Supervision** As an owner-managed company, we are completely independent in our decisions. Since 2002 Medical Strategy has been a member of the Association of Independent Asset Managers (VuV). Already since 1998 the company has been licensed for financial portfolio management by the Federal Financial Supervisory Authority (BaFin).
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Medical Strategy - Biotech Investors has 6 employees across 4 departments.
Departments
Number of employees
Funding Data
Medical Strategy - Biotech Investors has never raised funding before.
Medical Strategy - Biotech Investors Tech Stack
Discover the technologies and tools that power Medical Strategy - Biotech Investors's digital infrastructure, from frameworks to analytics platforms.
CDN
JavaScript libraries
JavaScript graphics
Cookie compliance
Analytics
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Programming languages
Video players
Cookie compliance
United States
Australia
Canada
Czechia
Spain
Frequently asked questions
4.8
40,000 users
